Increased levels of prolactin receptor expression correlate with the early onset of lupus symptoms and increased numbers of transitional-1 B cells after prolactin treatment

BMC Immunology

Volumn 13, Issue , 2012, Pages

  Ledesma Soto, Yadira ^a,d   Blanco Favela, Francisco ^a   Fuentes Pananá, Ezequiel M ^a   Tesoro Cruz, Emiliano ^a,b   Hernández González, Rafael ^b   Arriaga Pizano, Lourdes ^c   Legorreta Haquet, María V ^a   Montoya Diaz, Eduardo ^a   Chávez Sánchez, Luis ^a   Castro Mussot, María E ^d   Chávez Rueda, Adriana K ^a  

^a HOSPITAL DE PEDIATRÍA   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^c HOSPITAL DE ESPECIALIDADES   (Mexico)

^d INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

METOCLOPRAMIDE; PROLACTIN; PROLACTIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HYPERPROLACTINEMIA; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MOUSE; MOUSE STRAIN; NONHUMAN; PROLACTIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; SYMPTOM; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSITIONAL 1 B LYMPHOCYTE; ANIMAL; C57BL MOUSE; CYTOLOGY; GENE EXPRESSION; GENETICS; GERMINAL CENTER; IMMUNOLOGY; METABOLISM; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; PRE B LYMPHOCYTE; SPLEEN;

ANIMALS; B-LYMPHOCYTE SUBSETS; FEMALE; GENE EXPRESSION; GERMINAL CENTER; HYPERPROLACTINEMIA; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED C57BL; MICE, INBRED MRL LPR; PRECURSOR CELLS, B-LYMPHOID; PROLACTIN; RECEPTORS, PROLACTIN; SPLEEN;

EID: 84857951565     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-13-11     Document Type: Article

References (47)

1. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 1998, 19:225-268. 10.1210/er.19.3.225, 9626554.
2. Chavez-Rueda K, Hernandez J, Zenteno E, Leaños-Miranda A, Legorreta-Haquet MV, Blanco-Favela F. Identification of prolactin as a novel immunomodulator on the expression of co-stimulatory molecules and cytokine secretions on T and B human lymphocytes. Clin Immunol 2005, 116:182-191. 10.1016/j.clim.2005.03.013, 15993365.
3. Sodhi A, Tripathi A. Prolactin and growth hormone induce differential cytokine and chemokine profile in murine peritoneal macrophages in vitro: involvement of p-38 MAP kinase, STAT3 and NF-kappaB. Cytokine 2008, 41:162-173. 10.1016/j.cyto.2007.11.007, 18248819.
4. Tomio A, Schust DJ, Kawana K, Yasugi T, Kawana Y, Mahalingaiah S, Fujii T, Taketani Y. Prolactin can modulate CD4+ T-cell response through receptor-mediated alterations in the expression of T-bet. Immunol Cell Biol 2008, 86:616-621. 10.1038/icb.2008.29, 18414429.
5. Da Costa R, Szyper-Kravitz M, Szekanecz Z, Csépány T, Dankó K, Shapira Y, Zandman-Goddard G, Orbach H, Agmon-Levin N, Shoenfeld Y. Ferritin and prolactin levels in multiple sclerosis. Isr Med Assoc J 2011, 13:91-95.
6. Blanco-Favela F, Chavez-Rueda K, Leaños-Miranda A. Analysis of anti-prolactin auto antibodies in systemic lupus erythematosus. Lupus 2001, 10:757-761. 10.1191/096120301717165001, 11721703.
7. Leaños-Miranda A, Pascoe-Lira D, Chavez-Rueda KA, Blanco-Favela F. Persistence of macroprolactinemia due to antiprolactin autoantibody before, during, and after pregnancy in a woman with Systemic Lupus Erythematosus. J Clin Endocrinol Metab 2001, 86:2619-2624. 10.1210/jc.86.6.2619, 11397862.
8. Jara LJ, Benitez G, Medina G. Prolactin, dendritic cells, and systemic lupus erythematosus. Autoimmun Rev 2008, 7:251-255. 10.1016/j.autrev.2007.11.018, 18190887.
9. Orbach H, Zandman-Goddard G, Boaz M, Agmon-Levin N, Amital H, Szekanecz Z, Szucs G, Rovensky J, Kiss E, Doria A, Ghirardello A, Gomez-Arbesu J, Stojanovich L, Ingegnoli F, Meroni PL, Rozman B, Blank M, Shoenfeld Y. Prolactin and autoimmunity: hyperprolactinemia correlates with serositis and anemia in SLE patients. Clin Rev Allergy Immunol 2011, doi: 10.1007/s12016-011-8256-0.
10. Sousa GM, Oliveira RC, Pereira MM, Parana R, Sousa-Atta AM. Autoimmunity in hepatitis; C virus carriers: involvement of ferritin and prolactin. Autoimmun Rev 2011, 10:210-213. 10.1016/j.autrev.2010.10.003, 20951240.
11. Buskila D, Berezin M, Gur H, Lin HC, Alosachie I, Terryberry JW, Barka N, Shen B, Peter JB, Shoenfeld Y. Autoantibody profile in the sera of women with hyperprolactinemia. J Autoimmun 1995, 8:415-424. 10.1006/jaut.1995.0033, 7576002.
12. Grammer AC, Lipsky PE. B cell abnormalities in systemic lupus erythematosus. Arthritis Res Ther 2003, 5(Suppl 4):S22-S27. 10.1186/ar1009, 2833441, 15180894.
13. Yurasov S, Wardemann H, Hammersen J, Tsuiji M, Meffre E, Pascual V, Nussenzweig MC. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J Exp Med 2005, 201:703-7011. 10.1084/jem.20042251, 2212839, 15738055.
14. Montgomery DW. Prolactin production by immune cells. Lupus 2001, 10:665-675. 10.1191/096120301717164895, 11721692.
15. Goffin V, Binart N, Touraine P, Kelly PA. Prolactin: the new biology of an old hormona. Annu Rev Physiol 2002, 64:47-67. 10.1146/annurev.physiol.64.081501.131049, 11826263.
16. Günes H, Mastro AM. Prolactin receptor gene expression in rat splenocytes and thymocytes from birth to adulthood. Mol Cell Endocrinol 1996, 117:41-52. 10.1016/0303-7207(95)03724-1, 8734472.
17. Praprotnik S, Agmon-Levin N, Porat-Katz BS, Blank M, Meroni PL, Cervera R, Miesbach W, Stojanovich L, Szyper-Kravitz M, Rozman B, Tomsic M, Shoenfeld Y. Prolactin's role in the pathogenesis of the antiphospholipid syndrome. Lupus 2010, 9:1515-1559.
18. McMurray RW. Prolactin in murine systemic lupus erythematosus. Lupus 2001, 10:742-747. 10.1191/096120301717164985, 11721701.
19. Andrews BS, Eisenberg RA, Theofilopoulos AN, Izui S, McConahey PJ, Murphy ED, Roths JB, Dixon FJ. Spontaneous murine lupus-like syndromes. Clinical and Immunophatological manifestations in several strains. J Exp Med 1978, 148:1198-1215. 10.1084/jem.148.5.1198, 2185049, 309911.
20. Chan OT, Madaio MP, Shlomchik MJ. B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity. J Immunol 1999, 163:3592-3594.
21. Li Y, Chen F, Putt M, Koo YK, Madaio M, Cambier JC, Cohen PL, Eisenberg RA. B cell depletion with anti CD79 mAbs ameliorates autoimmune disease in MRL/lpr mice. J Immunol 2008, 181:2961-2972. 2865432, 18713966.
22. Allman D, Lindsley RC, DeMuth W, Rudd K, Shinton SA, Hardy RR. Resolution of three no proliferative immature splenic B cell subsets reveal multiple selection points during peripheral B cell maturation. J Immunol 2001, 167:6834-6840.
23. Orbach H, Shoenfeld Y. Hyperprolactinemia and autoimmune diseases. Autoimmun Rev 2007, 6:537-542. 10.1016/j.autrev.2006.10.005, 17854745.
24. Anaya JM, Shoenfeld Y. Multiple autoimmune diseases in a patient with hyperprolactinemia. Isr Med Assoc J 2005, 7:740-741.
25. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992, 356:314-317. 10.1038/356314a0, 1372394.
26. Morales P, Carretero MV, Geronimo H, Copín SG, Gaspar ML, Marcos MA, Martín-Pérez. Influence of prolactin on the differentiation of mouse B-lymphoid precursors. Cell Growth Differ 1999, 10:583-590.
27. Tussiwand R, Bosco N, Ceredig R, Rolink AG. Tolerance checkpoints in B-cell development: Johnny B good. Eur J Immunol 2009, 39:2317-2324. 10.1002/eji.200939633, 19714572.
28. Buckley AR. Prolactin a lymphocyte growth and survival factor. Lupus 2001, 10:684-690. 10.1191/096120301717164912, 11721694.
29. Kochendoerfer SK, Krishnan N, Buckley DJ, Buckley AR. Prolactin regulation of Bcl-2 family members: increased expression of bcl-xL but not mcl-1 or bad in Nb2-T cells. J Endocrinol 2003, 178:265-273. 10.1677/joe.0.1780265, 12904174.
30. Saha S, Gonzalez J, Rosenfeld G, Keiser H, Peeva E. Prolactin alters the mechanisms of B cell tolerance induction. Arthritis Rheum 2009, 60:1743-1752. 10.1002/art.24500, 2733916, 19479826.
31. McMurray R, Keisler D, Kanuckel K, Izui S, Walker SE. Prolactin influences autoimmune disease activity in the female B/W mouse. J Immunol 1991, 147:3780-3787.
32. Peeva E, Gonzalez J, Hicks R, Diamond B. Cutting edge: lupus susceptibility interval Sle3/5 confers responsiveness to prolactin in C57BL/6 mice. J Immunol 2006, 177:1401-1405.
33. Jara L, Gómez-Sánchez C, Silvera L, Martínez-Osuna P, Vasey F, Espinoza L. Hiperprolactinemia in systemic lupus erythematosus association with disease activity. Am J Med Sc 1992, 303:222-226.
34. Walker SE. Bromocriptine treatment of systemic lupus erythematosus. Lupus 2001, 10:762-768. 10.1191/096120301717165010, 11721704.
35. Peeva E, Michael D, Cleary J, Rice J, Chen X, Diamond B. Prolactin modulates the naive B cell repertoire. J Clin Invest 2003, 111:275-283. 151869, 12531884.
36. De León-Nava MA, Nava K, Soldevila G, López-Griego L, Chávez-Ríos JR, Vargas-Villavicencio JA, Morales-Montor J. Immune sexual dimorphism: effect of gonadal steroids on the expression of cytokines, sex steroid receptors, and lymphocyte proliferation. J Steroid Biochem Mol Biol 2009, 113:57-64. 10.1016/j.jsbmb.2008.11.003, 19073259.
37. García-Pérez MA, Del Val R, Noguera I, Hermenegildo C, Pineda B, Martinez-Romero A, Cano A. Estrogen receptor agonists and immune system in ovariectomized mice. Int J Immunopathol Pharmacol 2006, 19:807-819.
38. Sun R, Li AL, Wei HM, Tian ZG. Expression of prolactin receptor and response to prolactin stimulation of human NK cell lines. Cell Res 2004, 14:67-73. 10.1038/sj.cr.7290204, 15040892.
39. Cohen-Solal JF, Jeganathan V, Hill L, Kawabata D, Rodriguez-Pinto D, Grimaldi C, Diamond B. Hormonal regulation of B-cell function and systemic lupus erythematosus. Lupus 2008, 17:528-532. 10.1177/0961203308089402, 18539705.
40. Cambier JC, Gauld SB, Merrell KT, Vilen BJ. B cell anergy: from transgenic models to naturally occurring anergic B cell. Nat Rev Immunol 2007, 7:633-643. 10.1038/nri2133, 17641666.
41. Merrell KT, Benschop RJ, Gauld SB, Aviszus K, Decote-Ricardo D, Wysocki LJ, Cambier JC. Identification of anergic B cells within a wild-type repertoire. Immunity 2006, 25:953-962. 10.1016/j.immuni.2006.10.017, 17174121.
42. Teague BN, Pan Y, Mudd PA, Nakken B, Zhang Q, Szodoray P, Howard XK, Wilson PC, Farris D. Cutting edge: transitional T3 B cells do not give rise to mature B cells have undergone selection and are reduced in murine lupus. J Immunol 2003, 178:7511-7515.
43. Blair PA, Chavez-Rueda KA, Evans JG, Shlomchik MJ, Eddaoudi A, Isenberg DA, Ehrenstein MR, Mauri C. Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J Immunol 2009, 182:3492-3502. 10.4049/jimmunol.0803052, 19265127.
44. Pillai S, Cariappa A. The follicular versus marginal zone B lymphocyte cell fate decision. Nat Rev Immunol 2009, 9:767-777. 10.1038/nri2656, 19855403.
45. Kaminski DA, Stavnezer J. Enhanced IgA class switching in MZ and B1 B cells relative to follicular/B2 B cells. J Immunol 2006, 177:6025-6029.
46. Adachi M, Suematsu S, Suda T, Watanabe D, Fukuyama H, Ogasawara J, Tanaka T, Yoshida N, Nagata S. Enhanced and accelerated lymphoproliferation in Fas-null mice. PNAS 1996, 93:2131-2136. 10.1073/pnas.93.5.2131, 39922, 8700897.
47. Duan B, Niu H, Xu Z, Sharpe AH, Croker BP, Sobel ES, Morel L. Intrafollicular location of marginal zone/CD1dhi B cells is associated with autoimmune pathology in a mouse model of lupus. Lab Invest 2008, 88:1008-1020. 10.1038/labinvest.2008.62, 18607347.